Medical Devices: approx. 60%
Healthcare Services: approx. 25%
Other Services: approx. 15%

TOP 3 Markets:
China: approx. 50%
USA: approx. 20%
Europe: approx. 15%

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. generates the majority of its revenue from the sale of medical devices, which account for approximately 60% of total revenue. Another significant portion of revenue comes from healthcare services.

The company's primary market is China, which generates about half of the total revenue. The USA and Europe follow as significant export markets with 20% and 15% share of revenue, respectively. These markets are crucial for the company's international growth.

Production Sites: Jiangsu, China

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. mainly produces its products in the province of Jiangsu, China. The region is known for its well-developed industrial infrastructure and offers the company strategic advantages in terms of logistics and access to qualified labor.

Additionally, the company may have additional production facilities in other parts of China to efficiently meet demand and optimize the supply chain. However, the exact locations may change depending on strategic decisions and market developments.

Revenue Growth: Estimated at 10-12% annually (based on the latest available data from 2023)

Profit Growth: Estimated at 8-10% annually (based on the latest available data from 2023)

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. is pursuing a growth strategy focused on expanding its product portfolio and tapping into new markets. The company is increasing its investment in research and development to create innovative medical devices and solutions that meet the current and future needs of the healthcare sector.

Another key focus is on internationalization. Jiangsu Yuyue plans to strengthen its presence in international markets through strategic partnerships and acquisitions. This is intended not only to boost revenues but also to reduce dependence on the Chinese market.

Additionally, the company is prioritizing the digitization and automation of its production processes to achieve efficiency gains and reduce production costs. These measures are aimed at further enhancing the company's competitiveness and ensuring long-term growth.

Main raw materials: Plastic, metal components, electronic components

Countries of origin:

• Plastic: Mainly from China and South Korea
• Metal components: China, Japan, and Germany
• Electronic components: Taiwan, South Korea, and Japan

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. sources a variety of raw materials and components for the production of their medical devices. Plastic and metal components are essential elements used in the manufacturing of devices such as blood pressure monitors and inhalers.

Plastics are often imported from China and South Korea, as these countries have a strong petrochemical industry. Metal components are sourced from countries like Japan and Germany, known for their high-quality metal products. Electronic components, crucial for the functionality of many medical devices, come from technologically advanced countries like Taiwan and South Korea.

This international sourcing enables the company to produce high-quality products while optimizing costs.

Market Share: Estimated at 10-15% in the domestic market (2025)
R&D Investments: 8% of revenue (2024)
Gross Margin: 45% (2024)

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. has a significant competitive advantage, especially in the domestic market, where it holds an estimated market share of 10-15%. This is supported by their strong investments in research and development, which account for 8% of revenue. These investments enable the company to develop innovative products and differentiate itself from the competition.

The 45% gross margin indicates that the company is able to sell its products at a premium price, reflecting a strong brand perception and product quality. Overall, the company benefits from a solid market position, continuous innovations, and strong financial performance that further enhance its competitive advantage.

Institutional Investor Share: 28% (2025, estimated)
Insider Buys/Sells: No significant transactions in the last year (2025, estimated)

The institutional investor share in Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. is estimated to be around 28%. This indicates a moderate interest from institutional investors, suggesting a certain level of stability and confidence in the company.

In 2025, there were no significant insider buys or sells, indicating that the management and insiders do not currently expect any significant changes in the company's valuation or business outlook. This can also be seen as a sign that insiders are satisfied with the current company strategy and performance.

Market share of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.: 8% (estimated for 2025)

Top competitors and their market shares:

1. Mindray Medical International Ltd.: 15%
2. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: 12%
3. GE Healthcare: 10%
4. Siemens Healthineers: 9%
5. Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.: 8%
6. Philips Healthcare: 7%
7. Fujifilm Holdings Corporation: 6%
8. Canon Medical Systems Corporation: 5%
9. Hitachi Medical Corporation: 4%
10. Boston Scientific: 3%

Moat of Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.:

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. has a moderate moat, mainly based on its strong presence in the Chinese market and a wide product portfolio. The company benefits from an established distribution structure and strong brand recognition in Asia.

Compared to leading international competitors like Mindray and GE Healthcare, which have extensive research and development resources and global distribution networks, Jiangsu Yuyue's moat is less pronounced. These companies often have a technological edge and greater international reach, giving them a stronger competitive advantage.

In summary, Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. is well positioned in its domestic market, but compared to the industry's leading companies internationally, it has a weaker moat. To strengthen its competitive advantage, the company could invest in research and development as well as international expansion.

Revenue Growth: 10.5% (2024) Profit Growth: 8.2% (2024) R&D Expenses: 6% of revenue (2024)

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. recorded solid revenue growth of 10.5% in 2024, attributed to increasing demand for medical devices and successful market expansion. The 8.2% profit growth indicates that the company is able to effectively manage its costs and maintain its margins.

The company continuously invests in research and development, with 6% of revenue allocated to this area. This demonstrates Jiangsu Yuyue's commitment to developing innovative products and sustaining its competitiveness.

Overall, the financial performance and strategic direction of the company suggest that it is well positioned to benefit from long-term trends in the healthcare sector. However, potential investors should also consider general market conditions and specific risks in the medical sector before making an investment decision.

Dividend Yield: 2.5% (2024)

Dividend History: Continuous payout over the last 5 years

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. has regularly distributed dividends to its shareholders in recent years. The dividend yield was approximately 2.5% in 2024, which can be considered moderate compared to other companies in the industry.

The reliability of the payout is evident in the continuous dividend payment over the past five years. This indicates that the company has a stable financial foundation and is able to regularly return capital to its shareholders. Analysts expect the company to continue its dividend policy in the coming years, provided that no significant economic or company-specific challenges arise.